Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
21.2M
-
Shares change
-
-2.24M
-
Total reported value, excl. options
-
$281M
-
Value change
-
-$26.1M
-
Put/Call ratio
-
0.76
-
Number of buys
-
43
-
Number of sells
-
-34
-
Price
-
$13.25
Significant Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q4 2015
110 filings reported holding KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share as of Q4 2015.
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.2M shares
of 126M outstanding shares and own 16.79% of the company stock.
Largest 10 shareholders include FMR LLC (5.36M shares), FRANKLIN RESOURCES INC (5.17M shares), Palo Alto Investors, LLC (3.11M shares), MILLENNIUM MANAGEMENT LLC (1.29M shares), BlackRock Fund Advisors (1.04M shares), VANGUARD GROUP INC (702K shares), BlackRock Institutional Trust Company, N.A. (520K shares), Tekla Capital Management LLC (500K shares), STATE STREET CORP (341K shares), and NORTHERN TRUST CORP (250K shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.